Wells Fargo & Company Fulgent Genetics, Inc. Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
1 transactions
Others Institutions Holding FLGT
# of Institutions
201Shares Held
16.1MCall Options Held
2.04MPut Options Held
14K-
Black Rock Inc. New York, NY3.92MShares$71.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$26.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$23.3 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.11MShares$20.2 Million0.01% of portfolio
-
State Street Corp Boston, MA794KShares$14.5 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $554M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...